Illumina unveils AI software to predict disease-causing genetic mutations in patients
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an...
Stay updated with breaking news from David Mcalpine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an...
Published findings demonstrate PrimateAI-3D's ability to improve genetic risk prediction and drug target discovery using primate DNA and advanced artificial intelligence SAN DIEGO, June 1, 2023... | June 10, 2023
SAN DIEGO, May 31, 2023 /PRNewswire/ -- Illumina, Inc. announced today that it will host its third annual virtual Environment, Social and Corporate Governance focused investor event at 9:00 am... | May 31, 2023
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will host its third annual virtual Environment, Social and Corporate Governance (ESG)...
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of the latest data on the...